Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,842 | 698 | 40.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,040 | 4 | 26.2% |
| Consulting Fee | $5,960 | 3 | 22.2% |
| Travel and Lodging | $2,955 | 16 | 11.0% |
| Education | $73.87 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $14,401 | 125 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $4,522 | 83 | $0 (2024) |
| ABBVIE INC. | $1,492 | 111 | $0 (2024) |
| Corium, LLC | $1,018 | 80 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $880.84 | 42 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $694.60 | 48 | $0 (2022) |
| ITI, Inc. | $577.71 | 43 | $0 (2023) |
| Allergan, Inc. | $503.18 | 36 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $385.88 | 23 | $0 (2020) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $283.32 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,287 | 102 | ABBVIE INC. ($344.45) |
| 2023 | $1,693 | 127 | ITI, Inc. ($385.95) |
| 2022 | $1,423 | 89 | ABBVIE INC. ($487.81) |
| 2021 | $1,408 | 95 | AbbVie Inc. ($345.73) |
| 2020 | $1,187 | 61 | Supernus Pharmaceuticals, Inc. ($297.54) |
| 2019 | $4,327 | 79 | Supernus Pharmaceuticals, Inc. ($3,361) |
| 2018 | $7,500 | 93 | Shire North American Group Inc ($6,671) |
| 2017 | $8,046 | 80 | Shire North American Group Inc ($7,359) |
All Payment Transactions
726 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/18/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 352 | 690 | $83,523 | $30,540 |
| 2022 | 6 | 324 | 647 | $73,544 | $29,274 |
| 2021 | 7 | 376 | 714 | $74,262 | $31,877 |
| 2020 | 12 | 865 | 2,007 | $156,159 | $60,672 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 152 | $36,936 | $12,202 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $16,616 | $8,188 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 114 | $19,608 | $6,334 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,770 | $1,762 | 36.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $2,352 | $1,151 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,216 | $600.60 | 49.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 30 | $1,200 | $277.99 | 23.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 31 | 275 | $825.00 | $23.84 | 2.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 191 | $41,165 | $15,971 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $10,757 | $5,848 | 54.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 96 | $13,922 | $5,388 | 38.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $5,668 | $1,750 | 30.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 31 | $1,240 | $294.70 | 23.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 30 | 264 | $792.00 | $22.77 | 2.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 127 | 180 | $36,360 | $15,765 | 43.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 112 | $15,344 | $6,437 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 38 | 38 | $8,322 | $4,816 | 57.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $7,750 | $2,971 | 38.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $3,838 | $1,420 | 37.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 39 | 44 | $1,760 | $435.96 | 24.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 35 | 296 | $888.00 | $32.08 | 3.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 257 | 466 | $74,560 | $30,267 | 40.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 192 | 316 | $34,128 | $12,228 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 60 | 60 | $10,260 | $6,592 | 64.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 74 | 74 | $11,914 | $4,571 | 38.4% |
About Dr. John Cecil, M.D
Dr. John Cecil, M.D is a Pediatrics healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821168154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Cecil, M.D has received a total of $26,871 in payments from pharmaceutical and medical device companies, with $1,287 received in 2024. These payments were reported across 726 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($10,842).
As a Medicare-enrolled provider, Cecil has provided services to 1,917 Medicare beneficiaries, totaling 4,058 services with total Medicare billing of $152,363. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Location Paducah, KY
- Active Since 11/08/2006
- Last Updated 10/19/2016
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1821168154
Products in Payments
- MYDAYIS (Drug) $8,741
- VRAYLAR (Drug) $1,419
- VYVANSE (Drug) $1,334
- CAPLYTA (Drug) $861.03
- Azstarys (Drug) $684.96
- REXULTI (Drug) $625.65
- QELBREE (Drug) $615.17
- LATUDA (Drug) $361.36
- AZSTARYS (Drug) $333.51
- ABILIFY MAINTENA (Drug) $300.01
- QULIPTA (Drug) $291.23
- Adzenys XR-ODT (Drug) $266.20
- Auvelity (Drug) $242.57
- TROKENDI XR (Drug) $240.33
- TRINTELLIX (Drug) $200.63
- UBRELVY (Drug) $194.99
- JORNAY PM (Drug) $178.65
- ACTHAR (Biological) $147.16
- OXTELLAR XR (Drug) $139.08
- Trintellix (Drug) $123.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Paducah
Cynthia Bowman-Stroud, M.d, M.D
Pediatrics — Payments: $7,670
Caitlyn Cecil, M.d, M.D
Pediatrics — Payments: $4,259
Dr. John Roach, M.d, M.D
Pediatrics — Payments: $2,890
Jeffrey Mudd, Md, MD
Pediatrics — Payments: $1,971
Dr. Rachel Lowdenback, D.o, D.O
Pediatrics — Payments: $1,715
Kayla Mason, Md, MD
Pediatrics — Payments: $1,377